8月8日，华米科技(ZEPP)开盘上涨2.6%，截至21:30，报24.932美元/股，成交44.45万美元，总市值3.58 亿美元。 财务数据显示，截至2025年06月30日，华米科技收入总额9794.3万美元，同比增长21.52%；归母净利 润-2748.1万美元，同比减少7.32%。 大事提醒： 资料显示，Zepp Health Corporation(更名前:华米公司)是一家基于云的健康服务提供商,拥有全球领先的 智能可穿戴技术。华米科技也是中国首家登陆美国资本市场的智能硬件创新公司,于2018年2月在美国纽 约证券交易所(NYSE)上市(股票代码:ZEPP)。 公司的使命是"科技连接健康",通过"芯端云"的战略,布局芯片、智能可穿戴终端及健康云服务,构筑全球 健康生态,做用户最信赖的伙伴。基于强大的人工智能算法和大数据分析能力,华米科技为用户提供7x24 小时健康监测服务,并通过将智能可穿戴技术集成到全球物联网,为用户创造更智能、便捷的生活方式。 本文源自：金融界 作者：行情君 8月4日，华米科技2025财年中报归属股东应占溢利-2748万美元，同比下降7.32%，基本每股收益-0.11美 元。 ...

Group 1 - Zepp Health Corporation has experienced revenue drops and negative net income but shows potential for future growth following its transition to a new independent brand [1] - The stock is considered a strong buy option based on the current analysis [1] - The analysis emphasizes a bottom-up approach focusing on operational fundamentals, execution history, and sustainable growth drivers [1] Group 2 - The investment philosophy combines income and value investing strategies, highlighting the importance of dividend yield as a risk mitigation criterion [1] - The analyst prioritizes companies with smaller capitalization and low institutional coverage, identifying greater potential for asymmetries and alpha generation [1] - The analysis includes a triangulation approach involving valuation by multiples, discounted cash flow (DCF), and dividend yield [1]

8月7日，华米科技(ZEPP)盘中上涨6.42%，截至00:30，报25.605美元/股，成交2003.81万美元，总市值 3.68亿美元。 财务数据显示，截至2025年06月30日，华米科技收入总额9794.3万美元，同比增长21.52%；归母净利 润-2748.1万美元，同比减少7.32%。 大事提醒： 公司的使命是"科技连接健康",通过"芯端云"的战略,布局芯片、智能可穿戴终端及健康云服务,构筑全球 健康生态,做用户最信赖的伙伴。基于强大的人工智能算法和大数据分析能力,华米科技为用户提供7x24 小时健康监测服务,并通过将智能可穿戴技术集成到全球物联网,为用户创造更智能、便捷的生活方式。 本文源自：金融界 作者：行情君 8月4日，华米科技2025财年中报归属股东应占溢利-2748万美元，同比下降7.32%，基本每股收益-0.11美 元。 资料显示，Zepp Health Corporation(更名前:华米公司)是一家基于云的健康服务提供商,拥有全球领先的 智能可穿戴技术。华米科技也是中国首家登陆美国资本市场的智能硬件创新公司,于2018年2月在美国纽 约证券交易所(NYSE)上市(股票代码:ZEPP) ...

Group 1 - Xindong Company (02400) reported a positive earnings forecast, expecting revenue of at least RMB 3.05 billion for the first half of 2025, a year-on-year increase of approximately 37%, and a net profit of at least RMB 790 million, a year-on-year increase of about 215% [1] - Yimai Sunshine (02522) also announced a positive earnings forecast, expecting revenue between RMB 450 million to 480 million for the first half of the year, a year-on-year increase of approximately 8.77% to 16.03%, and a net profit of RMB 14.5 million to 16.5 million, a year-on-year increase of about 1350% to 1550% [1] - Tianli International Holdings (01773) plans to repurchase shares up to a total of HKD 200 million based on market conditions, believing that the share buyback plan is in the best interest of the company and its shareholders [2] Group 2 - Liaogang Co., Ltd. (02880) reported a total operating revenue of RMB 5.693 billion for the first half of 2025, a year-on-year increase of 5.93%, and a net profit attributable to shareholders of RMB 956 million, a year-on-year increase of 110.78% [2] - Yuan Zheng Technology (02488) reported a revenue of RMB 982 million for the first half of 2025, a year-on-year increase of 9.75%, and a net profit of RMB 195 million, a year-on-year increase of 27.74% [2] - Geekplus Technology (02590) expects revenue between RMB 995 million to 1.03 billion for the first half of the year, a year-on-year increase of 27% to 32%, while the net loss is expected to narrow significantly [3] Group 3 - Lee & Man Paper Manufacturing (02314) and other leading companies in the paper industry have initiated a price increase for various products starting August 1, indicating a significant acceleration in price adjustment frequency within the industry [3] - Xinda Biopharmaceutical (01801) announced that its innovative oral small molecule GLP-1R agonist IBI3032 has received IND approval from the FDA [4] - Heyu-B (02256) reported a revenue of RMB 612 million for the first half of the year, a year-on-year increase of 23.1%, and a net profit of RMB 328 million, a year-on-year increase of 58.84% [4] Group 4 - Bilibili (BILI.US) is expected to achieve a revenue growth of 20% year-on-year to RMB 7.3 billion in the second quarter, driven by stable performance in mobile games [5][6] - Li Auto (LI.US) launched the Li Xiang i8, with deliveries starting on August 20, and received positive outlooks from multiple institutions [6] - Xpeng Motors (XPEV.US) achieved a new monthly delivery record in July, delivering 36,717 smart electric vehicles, a year-on-year increase of 229% [7]

Group 1 - The top five gaining Chinese concept stocks at the close were Lichen International, ATA Creativity Global, Huami Technology, Puhua Biotechnology, and Feitian Zhaoye, with respective gains of 48.81%, 36.11%, 34%, 24.45%, and 23.46% [1] - Lichen International's latest price was 5.610, with a gain of 1.840 and a trading volume of 14.39 million [1] - ATA Creativity Global's latest price was 1.470, with a gain of 0.390 and a trading volume of 7.29 million [1] Group 2 - Huami Technology's latest price was 17.420, with a gain of 4.420 and a trading volume of 22.89 million [1] - Puhua Biotechnology's latest price was 0.8199, with a gain of 0.1611 and a trading volume of 1.36 million [1] - Feitian Zhaoye's latest price was 1.0000, with a gain of 0.1900 and a trading volume of 16.93 million [1]

Financial Data and Key Metrics Changes - ZEP Health Corporation achieved a remarkable 46% year-over-year increase in revenue, reaching $59.4 million, marking the first quarter of year-over-year revenue growth since 2021 [7][21] - Gross margin for Q2 2025 was 36.2%, consistent with Q1 2025 but slightly down year-over-year due to a higher proportion of lower-margin entry-level products [22] - Adjusted operating loss narrowed to $4.9 million, an improvement of 42% compared to the previous year [27] Business Line Data and Key Metrics Changes - The Amazfit brand was the sole contributor to revenue growth, with strong demand for the T Rex series and the introduction of new products like Balance two and Helios Chef [7][21] - The Balance two smartwatch targets multi-sport athletes and integrates advanced tracking features, contributing to the premiumization strategy [9][10] - The entry-level B6 and Active two series continued to see steady growth across major global markets, supported by retail and Amazon partnerships [11][12] Market Data and Key Metrics Changes - In the U.S., Amazfit ranked as the second most improved wearable brand year-over-year, with significant sales growth in the EMEA region, particularly in Germany, Italy, and France [20] - Prime Day sales surged by approximately 60% compared to the previous year, showcasing the effectiveness of marketing strategies [15] Company Strategy and Development Direction - The company is focused on a strategic transformation towards premium high-impact products, differentiating itself in the competitive wearable technology market [16] - ZEP Health is expanding its premium product portfolio and enhancing brand recognition through partnerships with athletes and targeted marketing campaigns [14][15] - The operational strategy includes a flexible supply chain and diversified manufacturing to mitigate tariff impacts and enhance competitiveness [13][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth and value revaluation as the market recognizes the company's efforts [32][33] - The outlook for Q3 2025 anticipates revenue in the range of $72 million to $76 million, representing 70% to 79% year-over-year growth [29] - Management expects gross margins to improve in the second half of the year due to a favorable product mix and new product launches [38][51] Other Important Information - The company has cumulatively retired $8 million of debt since 2023, optimizing its capital structure [28] - Research and development expenses increased by 4.2% year-over-year to $10.3 million, reflecting investments in new technologies [24] Q&A Session Summary Question: What are the drivers behind the recent spike in share price? - Management noted strong product reception and brand recognition, along with a value discovery journey in the market [32] Question: How many more product launches are expected in the second half of the year? - Management indicated that there will be exciting products in the pipeline for Q3 and Q4, matching or exceeding previous launches [35] Question: What gross margin can be expected for the full year? - Management expects gross margins to expand in the second half of the year, potentially reaching closer to 40% [37][38] Question: What percentage of imports to the U.S. comes from Vietnam, and what are the current tariffs? - Tariffs for products shipped from China to the U.S. are just below 25%, while those from Vietnam are close to zero due to tariff waivers [40] Question: What sales contribution is expected from the new Helios strap launch? - The Helios strap has received positive customer feedback and carries a healthy gross margin, with expectations for strong sales [48][51]

Financial Performance - Q2 2025 - Revenue reached $59.4 million, exceeding the company's guidance[8] - Adjusted net loss attributable to Zepp was -$6.2 million[9] - Units shipped totaled 0.7 million[9] Revenue Breakdown - Revenue from Amazfit-branded wearable products increased by 46.2% compared to Q2 2024[12] - In Q2 2025, Amazfit-branded wearable products accounted for 61.4% of total revenue, while Xiaomi wearable products accounted for 38.6%[12] - In H1 2025, Amazfit-branded wearable products accounted for 60.6% of total revenue, while Xiaomi wearable products accounted for 39.4%[13] Gross Margin - The total gross margin for Q2 2025 was 36.2%[20] - The gross margin for Amazfit-branded products in Q2 2025 was 43.6%[20] - The total gross margin for H1 2025 was 36.6%[26] - The gross margin for Amazfit-branded products in H1 2025 was 41.8%[26] Operating Expenses - Adjusted operating expenses for H1 2025 included G&A, S&M, and R&D[35] - Adjusted operating expenses as a percentage of total revenue for G&A was 10.5%, for S&M was 26.4%, and for R&D was 23.6%[37] Liquidity and Outlook - The company had a liquidity position of $95.3 million in cash and cash equivalents[47] - A share repurchase program of $16.0 million was in place until June 30, 2025[48] - The company expects net revenues to be between $72 million and $76 million for Q3 2025[52]

Investment Rating - The report maintains a "Positive" investment rating for the electronic industry, specifically focusing on the smart watch sector [3]. Core Insights - The smart watch industry is expected to continue its growth trajectory, driven by AI applications and increasing demand for sports functionalities [6][11]. - AI integration and sports features are becoming key selling points for smart watches, enhancing user experience and driving market demand [12][28]. Summary by Sections 1. Smart Watch Industry Growth - The smart watch segment is witnessing a steady increase in shipment volumes, with a significant rise in the share of smart watches equipped with operating systems, now accounting for approximately 80% of the wearable market [16][17]. - The global wearable market is recovering, with a 13% year-on-year increase in shipments in Q1 2025, indicating a positive trend for smart watches [19][22]. 2. AI Functionality and High-End Market - AI features are enhancing user interaction and health monitoring capabilities in smart watches, with predictions that AI watch penetration will reach 15% by 2025 [35][43]. - The demand for high-end smart watches is expected to rise, with advanced operating systems projected to dominate the market, potentially reaching 100 million units shipped by 2027 [52][56]. 3. Sports Watch Demand - The sports watch segment is characterized by specialized features for outdoor activities, with a higher average selling price compared to general smart watches, indicating a trend towards premiumization in the market [70]. - Garmin, a leader in the sports watch market, has shown strong revenue growth, reflecting the ongoing demand for high-performance sports watches [66][68]. 4. Investment Recommendations - The report suggests focusing on terminal manufacturers such as Huami Technology, Xiaomi Group, and Transsion Holdings, as well as SoC manufacturers like Hengxuan Technology, which are expected to benefit from market growth [14][74].

Core Points - Zepp Health Corporation will report its second quarter 2025 unaudited financial results on August 3, 2025 [1] - A conference call is scheduled for 9:30 p.m. ET on the same day, with access details provided for participants [1] - The company has shipped over 200 million units of its products and operates in more than 90 countries and regions [2] Company Overview - Zepp Health Corporation is a leader in smart wearables and health technology, focusing on optimizing health, fitness, and wellness journeys [2] - The company operates under consumer brands such as Amazfit, Zepp Clarity, and Zepp Aura, utilizing its proprietary Zepp Digital Management Platform [2] - Founded in 2013 as Huami Corp., the company rebranded to Zepp Health Corporation in February 2021 to emphasize its health focus [2]

Group 1 - Guolian Minsheng (01456) expects a net profit of RMB 1.129 billion for the first half of 2025, representing a year-on-year increase of approximately 1183% [1] - NIO-SW (09866) saw a rise of over 10% as its sub-brand, Lido, officially launched pre-sales for its new model L90, priced starting at RMB 279,900, which is competitive against similar models [1] - China CNR (01766) rose over 7% following a profit warning, with the rail transit equipment industry showing high demand and Q2 performance exceeding expectations [1] Group 2 - Coal stocks experienced a broad increase, with companies like China Qinfa (00866) and China Shenhua (01088) rising over 4%, driven by strong coal prices amid high temperatures [1] - Zijin Mining (02899) saw a rise of 1.5%, with expected net profit growth of about 54% year-on-year for the first half of the year, although short-term impacts from copper tariffs are anticipated [1] Group 3 - WanGuo Data-SW (09698) increased over 6% after its REIT completed offline inquiries with a subscription multiple of 166 times, indicating significant valuation potential [2] - Hengrui Medicine (01276) rose over 4%, reaching a new high, with expectations that its performance and business development will act as key catalysts [2] - China Shipbuilding Defense (00317) increased over 5% as the merger of two shipbuilding companies approaches completion, with Q2 performance exceeding expectations [2] Group 4 - Bitcoin-related stocks saw significant gains, with Bit Origin (BTOG.US) rising 51.72% and SharpLink Gaming (SBET.US) increasing 17.15%, driven by a surge in Bitcoin prices [3] - Gold stocks strengthened amid geopolitical tensions, with Gold ETF (GLD.US) rising 0.96% and Barrick Mining (B.US) increasing 0.71% [3] Group 5 - British Petroleum (BP.US) rose 3.55% as the company anticipates an increase in Q2 oil production and strong trading performance [7] - Huami Technology (ZEPP.US) surged over 69%, projecting a 30% revenue growth for Q2, marking its first growth in three years [7]